Τίτλος:
Patients’ preferences for headache acute and preventive treatment
Γλώσσες Τεκμηρίου:
Αγγλικά
Περίληψη:
Background: We aimed to explore patients’ preferences for headache treatments with a self-administered questionnaire including the Q-No questionnaire for nocebo. Methods: Questionnaires from 514 outpatients naïve to neurostimulation and monoclonal antibodies were collected. Results: Patients assessed that the efficacy of a treatment is more important than safety or route of administration. They preferred to use an external neurostimulation device for both acute (67.1%) and preventive treatment (62.8%). Most patients preferred to take a pill (86%) than any other drug given parenterally for symptomatic pharmaceutical treatment. For preventive pharmaceutical treatment, most patients preferred to take a pill once per day (52%) compared to an injection either subcutaneously or intravenously each month (9% and 4%), or three months (15% and 11%). 56.6% of all participants scored more than 15 in Q-No questionnaire indicating potential nocebo behaviors that contributed significantly in their choices. Conclusion: These patient preferences along with efficacy and safety data may help physicians better choose the right treatment for the right person. © 2017, The Author(s).
Συγγραφείς:
Mitsikostas, D.D.
Belesioti, I.
Arvaniti, C.
Mitropoulou, E.
Deligianni, C.
Kasioti, E.
Constantinidis, T.
Dermitzakis, M.
Vikelis, M.
on behalf of the Hellenic Headache Society
Περιοδικό:
The Journal of Headache and Pain
Εκδότης:
Springer-Verlag Italia s.r.l.
Λέξεις-κλειδιά:
analgesic agent; monoclonal antibody; analgesic agent; monoclonal antibody, adult; Article; chronic cluster headache; chronic tension headache; clinical article; clinical effectiveness; device safety; drug safety; episodic cluster headache; episodic migraine; episodic tension headache; female; human; male; nerve stimulation; nerve stimulator; nocebo effect; outpatient; patient preference; priority journal; prophylaxis; prospective study; Q No questionnaire; questionnaire; scoring system; transformed migraine; Greece; headache; implantable neurostimulator; middle aged; migraine; patient preference; preventive medicine; psychology; questionnaire; subcutaneous drug administration; utilization; young adult, Adult; Analgesics; Antibodies, Monoclonal; Female; Greece; Headache; Humans; Implantable Neurostimulators; Injections, Subcutaneous; Male; Middle Aged; Migraine Disorders; Patient Preference; Preventive Medicine; Surveys and Questionnaires; Young Adult
DOI:
10.1186/s10194-017-0813-3
